1. 388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors. (9th November 2020) Authors: Bendell, Johanna; Messersmith, Wells; Rasco, Drew; Wang-Gillam, Andrea; Park, Wungki; Zhou, Lei; Carter, Laura; Bruey, Jean-Marie; Li, Jack; Ferguson, Beatrice; Dupont, Jakob; Chaney, Marya; Bono, Johann De Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors. (9th November 2020) Authors: Bendell, Johanna; Messersmith, Wells; Rasco, Drew; Wang-Gillam, Andrea; Park, Wungki; Zhou, Lei; Carter, Laura; Bruey, Jean-Marie; Li, Jack; Ferguson, Beatrice; Dupont, Jakob; Chaney, Marya; Bono, Johann De Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors. (10th December 2020) Authors: Messersmith, Wells; Rasco, Drew; Bono, Johann De; Wang-Gillam, Andrea; Park, Wungki; Nickle, David; Galkin, Anna; Ferguson, Beatrice; Carter, Laura; Zhou, Lei; Dupont, Jakob; Chaney, Marya; Bendell, Johanna; Bruey, Jean-Marie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors. (9th November 2020) Authors: Messersmith, Wells; Rasco, Drew; Bono, Johann De; Wang-Gillam, Andrea; Park, Wungki; Nickle, David; Galkin, Anna; Ferguson, Beatrice; Carter, Laura; Zhou, Lei; Dupont, Jakob; Chaney, Marya; Bendell, Johanna; Bruey, Jean-Marie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗